A clinical case of COVID-19 in a patient with Hodgkin lymphoma and brain damage
G. K. Zoloev,
A. A. Kosovskikh,
O. V. Rudenkova,
Zh. V. Pikelgaupt,
V. V. Manzhos,
K. V. Cherevatenko https://doi.org/10.23946/2500-0764-2023-8-1-143-149
Abstract
Severe COVID-19 is not restricted to the lungs but also affects other organs and tissues, making the choice of the therapeutic regimen challenging, in particular with patients having comorbid conditions. Here we present the case of successful treatment of COVID-19 in patient with Hodgkin lymphoma and brain injury, focusing on the signs, symptoms, and differential diagnosis.
About the Authors
G. K. Zoloev
Grand Medica LLC; Novokuznetsk State Institute for Advanced Medical Training – Branch of the Russian Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
Prof. Georgy K. Zoloev, MD, DSc, Professor, Chief Physician; Professor, Department of Surgery, Urology, Endoscopy and Pediatric Surger
11, Kuznetskstroevskiy Prospekt, Novokuznetsk, 654007
5, Prospekt Stroiteley, Novokuznetsk, 654005
A. A. Kosovskikh
Grand Medica LLC; Novokuznetsk State Institute for Advanced Medical Training – Branch of the Russian Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
Dr. Andrey A. Kosovskikh, MD, PhD, Head of the Department of Anaesthesiology and Critical Care for COVID-19 patients; Associate Professor, Department of Anaesthesiology and Critical Care
11, Kuznetskstroevskiy Prospekt, Novokuznetsk, 654007
5, Prospekt Stroiteley, Novokuznetsk, 654005
O. V. Rudenkova
Grand Medica LLC
Russian Federation
Russian Federation
Dr. Olga V. Rudenkova, MD, PhD, Neurologist
11, Kuznetskstroevskiy Prospekt, Novokuznetsk, 654007
Zh. V. Pikelgaupt
Grand Medica LLC
Russian Federation
Russian Federation
Dr. Zhanna V. Pikelgaupt, MD, PhD, Head of the Department of Diagnostic Radiology
11, Kuznetskstroevskiy Prospekt, Novokuznetsk, 654007
V. V. Manzhos
Grand Medica LLC
Russian Federation
Russian Federation
Dr. Veronika V. Manzhos, MD, Head of the Department of Anaesthesiology and Critical Care for COVID-19 patients
11, Kuznetskstroevskiy Prospekt, Novokuznetsk, 654007
K. V. Cherevatenko
Grand Medica LLC
Russian Federation
Russian Federation
Dr. Kirill V. Cherevatenko, MD, Oncologist
11, Kuznetskstroevskiy Prospekt, Novokuznetsk, 654007
References
1. Petrikov SS, Ivannikov AA, Vasilchenko MK, Esaulenko AN, Alidzhanova KhG. COVID-19 and Cardiovascular System. Part 1. Pathophysiology, Pathomorphology, Complications, Long-Term Prognosis. Russian Sklifosovsky Journal of Emergency Medical Care. 2021;10(1):14-26. (in Russ). https://doi.org/10.23934/2223-9022-2021-10-1-14-26
2. Janardhan V, Janardhan V, Kalousek V. COVID‐19 as a blood clotting disorder masquerading as a respiratory illness: a cerebrovascular perspective and therapeutic implications for stroke thrombectomy. J Neuroimaging. 2020;30(5):555-561. https://doi.org/10.1111/jon.12770
3. Cani I, Barone V, D'Angelo R, Pisani L, Allegri V, Spinardi L, Malpassi P, Fasano L, Rinaldi R, Fanti S, Cortelli P, Guarino M. Frontal encephalopathy related to hyperinflammation in COVID-19. J Neuroimaging. 2021;268(1):16-19. https://doi.org/10.1007/s00415-020-10057-5
4. Vogrig A, Bagatto D, Gigli GL, Cobelli M, D'Agostini S, Bnà C, Morassi M. Causality in COVID-19-associated stroke: a uniform case definition for use in clinical research. J Neuroimaging. 2021;268(3):758-761. https://doi.org/10.1007/s00415-020-10103-2
5. Molochkov AV, Karateev DE, Ogneva EYu, Zulkarnaev AB, Luchikhina EL, Makarova IV, Semenov DYu. Comorbidities and predicting the outcome of COVID-19: the treatment results of 13,585 patients hospitalized in the Moscow Region. Almanac of Clinical Medicine. 2020;48(S1):1-10. (in Russ). https://doi.org/10.18786/2072-0505-2020-48-040
6. Guilmot A, Maldonado Slootjes S, Sellimi A, Bronchain M, Hanseeuw B, Belkhir L, Yombi JC, De Greef J, Pothen L, Yildiz H, Duprez T, Fillée C, Anantharajah A, Capes A, Hantson P, Jacquerye P, Raymackers JM, London F, El Sankari S, Ivanoiu A, Maggi P, van Pesch V. Immunemediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol. 2021;268(3):751-757. https://doi.org/10.1007/s00415-020-10108-x
7. Patel SD, Kollar R, Troy P, Song X, Khaled M, Parra A, Pervez M. Malignant Cerebral Ischemia in A COVID-19 Infected Patient: Case Review and Histopathological Findings. J Stroke Cerebrovasc Dis. 2020;29(11):105231. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105231
8. D'Anna L, Kwan J, Brown Z, Halse O, Jamil S, Kalladka D, Venter M, Banerjee S. Characteristics and clinical course of Covid-19 patients admitted with acute stroke. J Neurol. 2020;267(11):3161-3165. https:// doi.org/10.1007/s00415-020-10012-4
9. Balestrino R, Rizzone M, Zibetti M, Romagnolo A, Artusi CA, Montanaro E, Lopiano L. Onset of Covid-19 with impaired consciousness and ataxia: a case report. J Neurol. 2020;267(10):2797-2798. https://doi.org/10.1007/s00415-020-09879-0
10. Challenor S, Tucker D. SARS-CoV-2-induced remission of Hodgkin lymphoma. Br J Haematol. 2021;192(3):415. https://doi.org/10.1111/bjh.17116.
Review
For citations:
Zoloev G.K., Kosovskikh A.A., Rudenkova O.V., Pikelgaupt Zh.V., Manzhos V.V., Cherevatenko K.V. A clinical case of COVID-19 in a patient with Hodgkin lymphoma and brain damage. Fundamental and Clinical Medicine. 2023;8(1):143-149. (In Russ.) https://doi.org/10.23946/2500-0764-2023-8-1-143-149
Views:
301
Email this article 